Hysan Schnupfenspray

Xylometazoline Hydrochloride, the active ingredient in Hysan Schnupfenspray, is an alpha-adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Hysan Schnupfenspray as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Xylometazoline Hydrochloride acts on the nasal vasculature to reduce swelling and improve airflow in several upper‑respiratory conditions. - Common cold nasal congestion: Reduces mucosal edema to restore normal breathing. - Sinusitis‑related congestion: Decreases nasal passage swelling, facilitating sinus drainage. - Allergic rhinitis: Alleviates nasal blockage caused by allergic inflammation.

Adverse reactions may occur with any nasal decongestant spray.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing shortly after use. - Headache. - Altered taste or bitter taste. - Mild epistaxis (nosebleed).

Serious or Rare Side Effects: - Severe hypertension or hypertensive crisis. - Cardiac arrhythmias. - Rebound congestion (rhinitis medicamentosa) with prolonged use. - Allergic reactions such as rash, itching, or swelling. - Nasal ulceration or perforation. - Acute ocular pressure increase in susceptible individuals.

Before using Hysan Schnupfenspray, consider the following safety measures. - Do not exceed recommended frequency: limit to two sprays per nostril every 12 hours. - Avoid use longer than three consecutive days to prevent rebound congestion. - Caution in patients with hypertension: monitor blood pressure regularly. - Use with care in individuals taking other sympathomimetic agents. - Pregnant or breastfeeding women should consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline may interact with other medicines that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Concurrent use of other nasal decongestants: risk of additive vasoconstriction and hypertension. - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Sympathomimetic drugs (e.g., epinephrine): increased risk of cardiovascular stimulation.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: monitor for reduced efficacy. - Beta‑blockers: possible attenuation of cardiovascular response. - Cocaine or other intranasal stimulants: heightened risk of nasal tissue damage.